Standout Papers

Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane 2023 2026 202482
  1. Using Risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane (2023)
    Ella Flemyng, Theresa HM Moore et al. BMJ evidence-based medicine

Immediate Impact

1 from Science/Nature 33 standout
Sub-graph 1 of 11

Citing Papers

Bias recognition and mitigation strategies in artificial intelligence healthcare applications
2025 Standout
Alternative splicing and related RNA binding proteins in human health and disease
2024 Standout
3 intermediate papers

Works of Ella Flemyng being referenced

Digital contact tracing technologies in epidemics: a rapid review
2020
The RNA‐binding protein LARP4 regulates cancer cell migration and invasion
2016

Author Peers

Author Last Decade Papers Cites
Ella Flemyng 48 49 12 99 55 8 271
Hong Zhu 30 10 18 35 7 283
Patrik Bächtiger 24 22 20 101 18 268
Umberto Tachinardi 26 8 20 22 15 190
Bingqian Jiang 27 25 62 12 7 252
Salem Argaw 14 15 77 21 9 205
Dajiang Li 75 9 19 21 9 320
Kendall Jamieson Gilmore 87 24 14 40 10 191
Yu-Sheng Lo 30 4 19 66 14 323
Yi Huang 14 12 21 34 8 256
Mustafa Alwani 14 8 24 37 19 333

All Works

Loading papers...

Rankless by CCL
2026